Aqua Medical has named Robert 'Bob' Haggerty as president and chief executive officer, effective July 31, to lead the next phase of development for its diabetes treatment. Haggerty succeeds Lloyd Mencinger, who is stepping down after nine years at the helm.
Company Information
Company
Aqua Medical
Location
California, United States
About
Aqua Medical is developing minimally invasive endoscopic therapies for type 2 diabetes and Barrett’s Esophagus. The company is focused on advancing a proprietary radiofrequency vapor ablation platform designed for outpatient settings. Aqua Medical aims to expand access to interventional metabolic therapies. The company is targeting a large market with significant unmet needs.
Predictive Intelligence
Strategic
ML-powered predictions for Aqua Medical's next move